Elemental Impurities in the Pharmaceutical Industry
Key insights on guidelines, testing requirements, and analytical approaches for complying with the USP requirements for instrument-based heavy metals testing.
Key insights on guidelines, testing requirements, and analytical approaches for complying with the USP requirements for instrument-based heavy metals testing.
How pre-clinical tools used in the industry to study pharmacokinetics are used to guide the development of new chemical entities (NCEs).
The key considerations for transitioning a molecule from discovery to Phase 1.
Evaluate critical areas in the drug development process to help ensure a successful toxicology study.
A review and quantitative analysis of the molecular properties of approved drugs formulated as lipid systems
The key spray dried dispersion (SDD) development considerations to enhance and sustain in-vivo drug solubility.